Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if two investigational medications will be
more effective in decreasing urine output than the currently available and routinely used
medications in patients with congenital nephrogenic diabetes insipidus (NDI).